AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ENDRA Life Sciences Inc. Director's Dealing 2019

May 30, 2019

35444_dirs_2019-05-30_0419ca1f-e5ed-4b5e-96ed-f07851bae1d8.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2019-05-28

Reporting Person: Maloberti Renaud Bertrand (Chief Commercial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned	0	Direct